 The primary purpose is to prove the efficacy of treatment administration with Botulinum Toxin Type A for Injection HengLi beyond placebo in subjects with post-stroke upper limb spasticity of both wrist and fingers flexors as measured on the Modified Ashworth Scale MAS. 